Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025
a global leader in drug delivery, consumer product dosing, dispensing, and protection technologies, today announced its participation in the Jefferies Global Healthcare Conference, taking place on Wednesday, November 19, 2025. The annual event brings together leading healthcare companies, institutional investors, and industry analysts to discuss market trends, innovation, and strategic growth opportunities across the global healthcare landscape.Stephan Tanda, The President and Chief Executive Officer, will deliver a formal presentation at 7:00 a.m. Eastern Standard Time, highlighting the company’s recent performance, innovation-driven strategy, and long-term growth outlook. Vanessa Kanu, Executive Vice President and Chief Financial Officer, and Gael Touya, President of Aptar Pharma, will also be available during the conference to engage with investors and analysts.
Aptar’s Focus on Innovation and Sustainable Growth
They continue to be recognized as a trusted partner for some of the world’s most prominent pharmaceutical, consumer health, beauty, and food and beverage brands. The company’s participation in the Jefferies Global Healthcare Conference underscores its commitment to transparency with shareholders and its ongoing mission to enable healthier lives through innovative technology.
Under Stephan Tanda’s leadership, Aptar has accelerated its strategic focus on expanding its pharma and healthcare segments, which now represent the largest and fastest-growing part of its business portfolio. The company’s advanced delivery systems are used globally in nasal, pulmonary, injectables, and dermal drug delivery, serving critical therapeutic areas such as allergies, asthma, diabetes, pain management, and oncology.
Aptar has also strengthened its digital health capabilities through strategic collaborations and investments in connected devices and patient adherence technologies. These innovations are designed to improve treatment outcomes and enhance patient experiences, while providing valuable real-world data insights to healthcare providers and pharmaceutical partners.
Leadership in Sustainability and Operational Excellence
In addition to advancing its healthcare solutions, Aptar remains a leader in sustainable product design and manufacturing. The company continues to make progress toward its science-based climate targets, emphasizing circular materials, recyclable components, and carbon-efficient operations. Aptar’s efforts have earned recognition from prominent sustainability rating organizations such as EcoVadis, CDP, and Sustainalytics, reflecting the company’s dedication to environmental and social responsibility.
During the Jefferies presentation, Aptar’s leadership is expected to discuss how sustainability and innovation remain integral to the company’s business strategy, supporting long-term value creation for shareholders, customers, and communities worldwide.
A Strong Financial and Strategic Position
As of 2025, Aptar maintains a solid financial foundation, supported by steady revenue growth, disciplined capital allocation, and consistent cash flow generation. The company continues to invest in research and development, strategic acquisitions, and capacity expansion to meet growing customer demand across both established and emerging markets.
CFO Vanessa Kanu will provide insights into Aptar’s financial performance and capital strategy, emphasizing the company’s focus on maintaining operational resilience and driving shareholder value. Aptar’s balanced approach — combining innovation with financial discipline — positions it well for continued growth amid evolving market dynamics.
Gael Touya, President of Aptar Pharma, is expected to highlight recent developments within the company’s healthcare segment, including regulatory milestones, new customer partnerships, and product pipeline advancements that reinforce Aptar’s leadership in drug delivery technology.
Webcast and Investor Access
Investors and interested parties are invited to access a live audio webcast of the presentation and view the accompanying slides in the “Investors” section of Aptar’s corporate A replay of the webcast and presentation materials will remain available on the site following the event.
About Aptar
Aptar is a global leader in drug delivery and consumer product dosing, dispensing and protection technologies. Aptar serves a number of attractive end markets including pharmaceutical, beauty, food, beverage, personal care and home care. Using market expertise, proprietary design, engineering and science to create innovative solutions for many of the world’s leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 13,000 dedicated employees in 20 countries.
Source link: https://www.businesswire.com
